医药行业上市公司研发支出与企业成长性的相关性研究

发布时间：2018-03-20 02:15

本文选题：医药行业　切入点：RD支出　出处：《合肥工业大学》2017年硕士论文　论文类型：学位论文

【摘要】：在知识经济时代,一个国家要保证自己的长期的稳定发展的话,创新是必不可少的。对一个企业来说,要想保持核心竞争力,必须要提供源源不断的研发支出成果,走高科技的路线,如果能够走高科技的路线的话,对于企业的发展来说,肯定是可以提供一个长期和稳定的发展模式。作为研发支出绝对数与相对数都很高的医药行业来说,加之医药行业本身的高投入、高风险和高回报等特点,研究我国医药行业上市公司研发支出对企业成长性的影响具有重大的理论和现实意义。本文分别从企业成长性的含义、研发支出对企业成长性的影响机理以及研发支出对企业成长相关性关系层面的研究三个方面进行论述,首先对研发支出与企业成长性相关关系的文献进行综述,并对国内外前人学者的研究成果进行归纳总结。其次阐述了本文研究地理论基础与相关概念的界定,为下文进行实证研究提供理论依据和数据筛选范围的界定。然后在实证研究方面,本文分别从样本数据选取、变量指标的选取、实证假设与检验三个方面进行,运用因子分析法和主成分分析法对企业成长性指标进行综合分析,最后建立一个多元线性回归方程对所作出的假设进行验证,探索医药行业上市公司企业研发支出与企业成长性的相关关系,同时我们根据实证检验的结果对医药行业研发支出的现状和未来提出相应建议。
[Abstract]:In the era of knowledge economy, a country must ensure their long-term stable development, innovation is essential. For an enterprise, in order to maintain core competitiveness, we must provide Everfount spending on research and development achievements, take the high road, if we can take the high route, for the development of enterprises sure, it may provide a long-term and stable development. As the absolute number and relative number of R & D expenditures are high and the pharmaceutical industry, the pharmaceutical industry is a high input, high risk and high return characteristics, it is of great theoretical and practical importance to study the influence of R & D expenditure of listed companies on corporate growth China's pharmaceutical industry. This paper from the meaning of enterprise growth, the impact of R & D expenditure mechanism and the relationship between the level of R & D expenditures on Enterprise Growth Research on Enterprise Growth The three aspects are reviewed firstly, R & D expenditures and enterprise growth related literature, and the domestic and foreign scholars research achievements are summarized. Secondly, the definition of related concepts and theoretical basis of this research, empirical research and provide a theoretical basis for the following definition and scope of data screening then, in the empirical research, this paper from the selected sample data, select variables, the three aspects of the empirical hypothesis and test, by using the method of factor analysis and principal component analysis index to analyze the growth of enterprises, and finally establish a multiple linear regression equation to make hypotheses, explore the relationship of Listed Companies in pharmaceutical industry R & D expenditure and enterprise growth, at the same time, we according to the empirical results on the current situation of pharmaceutical industry research and development Make suggestions for the future.

【学位授予单位】：合肥工业大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72;F406.7;F273.1

【相似文献】